Monogenic forms of diabetes can result from mutations in genes encoding transcription factors. Mutations in the homeodomain transcription factor IDX-1, a critical regulator of pancreas development and insulin gene transcription, confer a strong predisposition to the development of diabetes mellitus in humans. To investigate the role of IDX-1 expression in the pathogenesis of diabetes, we developed a model for the inducible impairment of IDX-1 expression in pancreatic β cells in vivo by engineering an antisense ribozyme specific for mouse IDX-1 mRNA under control of the reverse tetracycline transactivator (rtTA). Doxycycline-induced impairment of IDX-1 expression reduced activation of the Insulin promoter but activated the Idx-1 promoter, suggesting that pancreatic β cells regulate IDX-1 transcription to maintain IDX-1 levels within a narrow range. In transgenic mice that express both rtTA and the antisense ribozyme construct, impaired IDX-1 expression elevated glycated hemoglobin levels, diminished glucose tolerance, and decreased insulin/glucose ratios. Metabolic phenotypes induced by IDX-1 deficiency were observed predominantly in male mice over 18 months of age, suggesting that cellular mechanisms to protect IDX-1 levels in pancreatic β cells decline with aging. We propose that even in the absence of Idx-1 gene mutations, pathophysiological processes that decrease IDX-1 levels are likely to impair glucose tolerance. Therapeutic strategies to attain normal glucose homeostasis by restoring normal IDX-1 levels may be of particular importance for older individuals with diabetes mellitus.
Melissa K. Thomas, Octavia N. Devon, Jee H. Lee, Andreas Peter, David A. Schlosser, Matthew S. Tenser, Joel F. Habener
Title and authors | Publication | Year |
---|---|---|
Mutant Huntingtin Impairs Pancreatic β-cells by Recruiting IRS-2 and Disturbing the PI3K/AKT/FoxO1 Signaling Pathway in Huntington’s Disease
L Li, Y Sun, Y Zhang, W Wang, C Ye |
Journal of Molecular Neuroscience | 2021 |
Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency
ED Franco, C Shaw-Smith, SE Flanagan, EL Edghill, J Wolf, V Otte, F Ebinger, P Varthakavi, T Vasanthi, S Edvardsson, AT Hattersley, S Ellard |
Diabetic Medicine | 2013 |
Conditional gene expression systems in the transgenic rat brain
K Schönig, T Weber, A Frömmig, L Wendler, B Pesold, D Djandji, H Bujard, D Bartsch |
BMC Biology | 2012 |
Maintenance of -Cell Maturity and Plasticity in the Adult Pancreas: Developmental Biology Concepts in Adult Physiology
M Szabat, FC Lynn, BG Hoffman, TJ Kieffer, DW Allan, JD Johnson |
Diabetes | 2012 |
β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
KL Egerod, C Jin, PS Petersen, N Wierup, F Sundler, B Holst, TW Schwartz |
International Journal of Endocrinology | 2011 |
Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue
L Zhang, Y Zhou, AY Zhu, X Li, SS Mundt, L Gao, JM Lisnock, M Hernandez, M Alonso-Galicia, MS Springer, EA O’Neill, BL Daugherty, O Puig |
Transgenic Research | 2011 |
Type 2 Diabetes and the Aging Pancreatic Beta Cell
U Gunasekaran, M Gannon |
Aging | 2011 |
A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase
Y Zou, CH Chen, JR Fike, TT Huang |
genesis | 2009 |
Modeling multiple sclerosis in laboratory animals
B Schreiner, FL Heppner, B Becher |
Seminars in Immunopathology | 2009 |
PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter
BR Burkhardt, JR Cook, RA Young, BA Wolf |
Biochimica et Biophysica Acta | 2008 |
A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis
DA Babu, TG Deering, RG Mirmira |
Molecular Genetics and Metabolism | 2007 |
Transcriptional regulation of the distal promoter of the rat pyruvate carboxylase gene by hepatocyte nuclear factor 3β/Foxa2 and upstream stimulatory factors in insulinoma cells
T Boonsaen, P Rojvirat, KH Surinya, JC Wallace, S Jitrapakdee |
Biochemical Journal | 2007 |
Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2
SY Yeom, GH Kim, CH Kim, HD Jung, SY Kim, JY Park, YK Pak, DK Rhee, SQ Kuang, J Xu, DJ Han, DK Song, JW Lee, KU Lee, SW Kim |
Molecular and cellular biology | 2006 |
Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells
H Wang, M Iezzi, S Theander, PA Antinozzi, BR Gauthier, PA Halban, CB Wollheim |
Diabetologia | 2005 |
Identification of PCIF1, a POZ Domain Protein That Inhibits PDX-1 (MODY4) Transcriptional Activity
A Liu, BM Desai, DA Stoffers |
Molecular and cellular biology | 2004 |
Transcriptional networks controlling pancreatic development and beta cell function
JM Servitja, J Ferrer |
Diabetologia | 2004 |
Increased islet apoptosis in PDX-1+/- mice
James D. Johnson, Noreen T. Ahmed, Dan S. Luciani, Zhiqiang Han, Hung Tran, Jun Fujita, Stanley Misler, Helena Edlund, Kenneth S. Polonsky |
Journal of Clinical Investigation | 2003 |
Lessons for human diabetes from experimental mouse models
RN Kulkarni, A Zisman |
Current Diabetes Reports | 2003 |
Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes
Z Wang, E Moro, K Kovacs, R Yu, S Melmed |
Proceedings of the National Academy of Sciences | 2003 |
Developmental aspects of the endocrine pancreas
Daniel M Kemp, Melissa K Thomas, Joel F Habener |
Reviews in Endocrine and Metabolic Disorders | 2003 |
PDX1 restores beta-cell function in IRS2 knockout mice
Jake A. Kushner, Jing Ye, Markus Schubert, Deborah J. Burks, Matthew A. Dow, Carrie L. Flint, Sanjoy Dutta, Christopher V.E. Wright, Marc R. Montminy, Morris F. White |
Journal of Clinical Investigation | 2002 |
Experimental control of pancreatic development and maintenance
AM Holland, MA Hale, H Kagami, RE Hammer, RJ MacDonald |
Proceedings of the National Academy of Sciences | 2002 |